Literature DB >> 17169438

Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization.

Csaba Jeney1, Tibor Takács, Attila Sebe, Zsuzsa Schaff.   

Abstract

There are several genital HPV DNA detection systems described, however most of them present different disadvantages regarding the number of amplified and detected types, sensitivity, type specificity. A new PCR and hybridization based detection method was developed for sensitive and balanced amplification and specific typing of HPV DNA from clinical samples. The technique amplifies and detects 46 HPV types: 2a, 3, 6, 7, 10, 11, 13, 16, 18, 26, 27, 28, 29, 30, 31, 33, 34, 35, 39, 40, 42, 43, 44/55, 45, 51, 52, 53, 54, 56, 57, 58, 59, 61, 66, 67, 68, 70, 72, 73(MM9), 74, 82(MM4), 84(MM8), 89, 90, 91. Key elements of the L1F/L1R PCR and hybridization system are: the special selection of the amplified region, a novel and optimized amplification primer set, circumspectly designed general and type-specific oligonucleotide probes. Detection following a multiplex PCR is based on solid phase hybridization in microtiter plate format using general and type-specific probes at medium stringency, which makes the detection robust in case of small sequence variations. The assay is highly reproducible and suitable for automation. The method was compared to Hybrid Capture II test, and after clarifying conflicting results, the comparison showed an excellent agreement (96.2%).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169438     DOI: 10.1016/j.jviromet.2006.10.013

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.

Authors:  Norbert Varga; Johanna Mózes; Helen Keegan; Christine White; Lynne Kelly; Loretto Pilkington; Márta Benczik; Schaff Zsuzsanna; Gábor Sobel; Róbert Koiss; Edit Babarczi; Miklos Nyíri; Laura Kovács; Sebe Attila; Borbála Kaltenecker; Adrienn Géresi; Adrienn Kocsis; John O'Leary; Cara M Martin; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-08-06       Impact factor: 3.201

2.  Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.

Authors:  Christine C Roberts; Ryan Swoyer; Janine T Bryan; Frank J Taddeo
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

3.  Rheonix CARD(®) Technology: An Innovative and Fully Automated Molecular Diagnostic Device.

Authors:  Gwendolyn Spizz; Lincoln Young; Rubina Yasmin; Zongyuan Chen; Travis Lee; Deborah Mahoney; Xun Zhang; Greg Mouchka; Benjamin Thomas; Whitney Honey; Todd Roswech; Cristina McGuire; Richard Montagna; Peng Zhou
Journal:  Point Care       Date:  2012-03-01

4.  Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses.

Authors:  Jae-jin Choi; Chunhee Kim; Heekyung Park
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

5.  A Study of Prognostic Factors in Young Patients With Non-HPV Oral Cancer in Central Europe.

Authors:  Katalin Csurgay; Attila Zalatnai; Márta Benczik; Benedek Krisztián Csomó; Ferenc Horváth; Ádám Lőrincz; György Komlós; Zsolt Németh
Journal:  Pathol Oncol Res       Date:  2021-12-22       Impact factor: 3.201

6.  Loop-Mediated Isothermal Amplification Assay for Detecting Tumor Markers and Human Papillomavirus: Accuracy and Supplemental Diagnostic Value to Endovaginal MRI in Cervical Cancer.

Authors:  Benjamin Wormald; Jesus Rodriguez-Manzano; Nicolas Moser; Ivana Pennisi; Thomas E J Ind; Katherine Vroobel; Ayoma Attygalle; Pantelis Georgiou; Nandita M deSouza
Journal:  Front Oncol       Date:  2021-11-01       Impact factor: 6.244

Review 7.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.